| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.0M | -5.0% |
| Cost of Revenue | $1.3M | +4.1% |
| R&D Expense | $9.2M | -0.3% |
| SG&A Expense | $6.4M | +4.6% |
| Operating Income | -$2.2M | +63.6% |
| Pre-tax Income | -$1.7M | +72.5% |
| Income Tax | $49K | +118.2% |
| Net Income | -$1.7M | +70.4% |
| EPS (Basic) | -$0.08 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.7M | -60.8% |
| Accounts Receivable | $3.3M | -11.9% |
| Current Assets | $37.3M | -4.0% |
| Total Assets | $51.2M | +5.8% |
| Current Liabilities | $5.8M | +1.1% |
| Stockholders' Equity | $40.2M | -3.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +19.1% |
| Capital Expenditures | $730K | +2603.7% |
| Investing Cash Flow | -$12.0M | -384.0% |
| Financing Cash Flow | -$1.2M | -1186.2% |
| Free Cash Flow | -$5.8M | +7.8% |
| +70.4% |
| EPS (Diluted) | -$0.08 | +70.4% |